Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
8- 10.16Regular26.10.16 22:426-KKey event#●●●#●●●#●●●
INSTINCT BIO TECHNICAL CO HOLDINGS INC.
Instinct Bio Technical (BIOT) reported revenue of $1,142,598 and a net profit of $90,251 for the first half of fiscal 2026, marking a return to profitability. While revenue grew 9.8% in yen terms compared to the same period last year, cash and bank balances decreased to $25,565, leaving the company dependent on support from directors and related parties for liquidity.…more
$0.1850+2.61%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.1Pre-market26.10.01 19:016-KKey event
INSTINCT BIO TECHNICAL CO HOLDINGS INC.
Instinct Bio Technical (BIOT) has been appointed by CelSiege Biosciences as a non-exclusive authorized representative for its clinical-stage cancer immunotherapy, IN01, in Japan and China. BIOT will facilitate business development activities, including identifying strategic partners, investment opportunities, and potential licensing or co-development collaborations in these markets.…more
$0.1850+2.61%vs prev closeView filingShare - 9.15Pre-market26.09.15 21:446-KKey event
INSTINCT BIO TECHNICAL CO HOLDINGS INC.
Instinct Bio has received notifications from Nasdaq regarding non-compliance with the minimum market value of listed securities (MVLS), minimum market value of publicly held shares (MVPHS), and minimum bid price requirements. The company has been granted a 180-day compliance period until March 8 and 9, 2027, to regain compliance and is currently evaluating its options.…more
$0.1850+2.61%vs prev closeView filingShare
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.4Pre-market26.09.04 20:00#●●●#●●●#●●●
Instinct Bio Provides Operational Update on Indonesia Clinic and Product Development…more
Instinct Bio has commenced construction on its first clinic in Jakarta and outlined plans for new cosmetic product lines with its partners. As these initiatives are still in the development phase without confirmed revenue impact, the update remains preliminary.…more
$0.1850+2.61%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 7.29Regular26.07.29 23:28
●●●●●●●● ●●●●● ●●●●●●
인스팅트 바이오가 인도네시아 시장에 일본 브랜드 'GENRÊVER CLINIC'을 론칭하며 구독 기반의 미용 의료 서비스를 시작합니다. 이번 사업은 안정적인 반복 매출 구조를 확보하고 향후 재생 의학 사업과의 시너지를 창출하기 위한 전략적 행보로 풀이됩니다.…more
$0.1850+2.61%vs prev close
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report